NO981252L - Transdermalt matrikssystem - Google Patents

Transdermalt matrikssystem

Info

Publication number
NO981252L
NO981252L NO981252A NO981252A NO981252L NO 981252 L NO981252 L NO 981252L NO 981252 A NO981252 A NO 981252A NO 981252 A NO981252 A NO 981252A NO 981252 L NO981252 L NO 981252L
Authority
NO
Norway
Prior art keywords
weight
parts
matrix system
group
transdermal matrix
Prior art date
Application number
NO981252A
Other languages
English (en)
Other versions
NO981252D0 (no
Inventor
Marie-Christine Math
Eric Teillaud
Bruno Bevan
Original Assignee
Lhd Lab Hygiene Dietetique
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lhd Lab Hygiene Dietetique filed Critical Lhd Lab Hygiene Dietetique
Publication of NO981252D0 publication Critical patent/NO981252D0/no
Publication of NO981252L publication Critical patent/NO981252L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Steroid Compounds (AREA)
  • Soy Sauces And Products Related Thereto (AREA)
  • Absorbent Articles And Supports Therefor (AREA)
  • Telephonic Communication Services (AREA)

Abstract

Et nytt transdermalt matrikssystem for perkutan avlevering av et hormon inkludert en bærer og en adhesivmatriks. Matriksen omfatter (a) 39 til 61 vektdeler av en etylen/vinylacetatkopolymer, (b) 12 til 17 vektdeler 2-oktyldodecylmyristat, (c) 5 til 17 vektdeler dietylftalat, (d) l O til 16 vektdeler av en forbindelse valgt blant N-alkyl-2-pyrrolidoner der alkyl- gruppen er en C4.I5-gruppe, og (e) l til 12 vektdeler av minst et hormon valgt fra gruppen estrogeniske og progestiniske komponenter. Det beskrives en fremgangsmåte for fremstilling av dette transdermale matrikssystem samt den terapeutiske anvendelse av systemet.
NO981252A 1995-09-27 1998-03-19 Transdermalt matrikssystem NO981252L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9511326A FR2739032B1 (fr) 1995-09-27 1995-09-27 Systeme matriciel transdermique d'administration d'un oestrogene et/ou d'un progestatif a base d'eva, procede de preparation et utilisation en therapeutique
PCT/FR1996/001494 WO1997011687A1 (fr) 1995-09-27 1996-09-25 Systeme matriciel transdermique

Publications (2)

Publication Number Publication Date
NO981252D0 NO981252D0 (no) 1998-03-19
NO981252L true NO981252L (no) 1998-03-19

Family

ID=9482961

Family Applications (1)

Application Number Title Priority Date Filing Date
NO981252A NO981252L (no) 1995-09-27 1998-03-19 Transdermalt matrikssystem

Country Status (25)

Country Link
US (1) US6013276A (no)
EP (1) EP0852492B1 (no)
JP (1) JPH11514988A (no)
KR (1) KR19990063732A (no)
CN (1) CN1083259C (no)
AT (1) ATE209031T1 (no)
AU (1) AU702542B2 (no)
BG (1) BG102322A (no)
BR (1) BR9610665A (no)
CA (1) CA2233162A1 (no)
CZ (1) CZ95398A3 (no)
DE (1) DE69617252T2 (no)
DK (1) DK0852492T3 (no)
EE (1) EE9800082A (no)
ES (1) ES2170266T3 (no)
FR (1) FR2739032B1 (no)
HU (1) HUP9900375A3 (no)
IL (1) IL123594A0 (no)
NO (1) NO981252L (no)
NZ (1) NZ319181A (no)
PL (1) PL325644A1 (no)
PT (1) PT852492E (no)
SK (1) SK282613B6 (no)
TR (1) TR199800563T1 (no)
WO (1) WO1997011687A1 (no)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10211832A1 (de) * 2002-03-16 2003-10-02 Lohmann Therapie Syst Lts Hormonhaltiges transdermales therapeutisches System mit einem Wirkstoffreservoir auf der Basis von Vinylacetat-Vinylpyrrolidon-Copolymer mit verbesserter Kohäsion
WO2004096151A2 (en) * 2003-04-29 2004-11-11 The General Hospital Corporation Methods and devices for the sustained release of multiple drugs
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
HRP20211377T1 (hr) 2011-11-23 2022-01-07 Therapeuticsmd, Inc. Prirodne kombinirane hormonske supstitucijske formulacije i terapije
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
CA2947767A1 (en) 2014-05-22 2015-11-26 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
JP2019513709A (ja) 2016-04-01 2019-05-30 セラピューティックスエムディー インコーポレーテッドＴｈｅｒａｐｅｕｔｉｃｓｍｄ， Ｉｎｃ． ステロイドホルモン薬学的組成物
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3049628C2 (de) * 1980-12-31 1982-10-21 Basf Ag, 6700 Ludwigshafen Verfahren zur Überwachung des Entstehens und Fortschreitens von Rissen in Maschinenteilen und Bauteilen sowie eine Vorrichtung zur Durchführung des Verfahrens
JPS58189115A (ja) * 1982-04-30 1983-11-04 Kowa Co 外用剤
US4816258A (en) * 1987-02-26 1989-03-28 Alza Corporation Transdermal contraceptive formulations
FR2612785A1 (fr) * 1987-03-25 1988-09-30 Lhd Lab Hygiene Dietetique Dispositif auto-adhesif d'administration d'un principe actif par voie percutanee
JPH03275619A (ja) * 1990-03-23 1991-12-06 Nitsusui Seiyaku Kk 外用剤組成物
US5286490A (en) * 1990-05-04 1994-02-15 Colgate-Palmolive Company Transdermal fluoride medication
US5122382A (en) * 1990-10-29 1992-06-16 Alza Corporation Transdermal contraceptive formulations, methods and devices
US5453279A (en) * 1992-04-21 1995-09-26 Tbs Laboratories, Inc. Enhancing transdermal absorption compositions; transdermal dosage form; and process
FR2717688B1 (fr) * 1994-03-28 1996-07-05 Lhd Lab Hygiene Dietetique Système matriciel transdermique d'administration d'un oestrogène et/ou un progestatif à base d'EVA.

Also Published As

Publication number Publication date
EP0852492A1 (fr) 1998-07-15
DE69617252T2 (de) 2002-07-25
IL123594A0 (en) 1998-10-30
CN1197390A (zh) 1998-10-28
BR9610665A (pt) 1999-07-13
ES2170266T3 (es) 2002-08-01
MX9802327A (es) 1998-08-30
NO981252D0 (no) 1998-03-19
BG102322A (en) 1998-10-30
AU702542B2 (en) 1999-02-25
NZ319181A (en) 1998-10-28
DE69617252D1 (de) 2002-01-03
CA2233162A1 (en) 1997-04-03
FR2739032A1 (fr) 1997-03-28
HUP9900375A3 (en) 1999-11-29
KR19990063732A (ko) 1999-07-26
HUP9900375A2 (hu) 1999-06-28
ATE209031T1 (de) 2001-12-15
SK282613B6 (sk) 2002-10-08
US6013276A (en) 2000-01-11
SK40698A3 (en) 1998-09-09
TR199800563T1 (xx) 1998-06-22
EE9800082A (et) 1998-10-15
AU7134996A (en) 1997-04-17
PL325644A1 (en) 1998-08-03
PT852492E (pt) 2002-05-31
JPH11514988A (ja) 1999-12-21
WO1997011687A1 (fr) 1997-04-03
FR2739032B1 (fr) 1997-11-21
EP0852492B1 (fr) 2001-11-21
CN1083259C (zh) 2002-04-24
DK0852492T3 (da) 2002-05-13
CZ95398A3 (cs) 1998-07-15

Similar Documents

Publication Publication Date Title
NO981252L (no) Transdermalt matrikssystem
NO981315L (no) Transdermalt matrikssystem
ATE194287T1 (de) Gaba-rezeptor-modulatoren
IL99571A (en) Process for the preparation of water soluble 10-hydroxy-9-(substituted methyl)camptothecin analogs
ES2142000T3 (es) Derivados del acido metoxiiminoacetico y fungicidas agricolas y horticolas que los contienen como ingrediente activo.
ES2167463T3 (es) Componentes de un compuesto medicinal que comprenden derivados n-sustituidos de la o-toluidina y preparacion percutaneamente absorbible.
DE3866408D1 (de) Selbstklebende vorrichtung zur transdermalen verabreichung eines wirkstoffs.
DK164326C (da) 6,6-ethylen-15,16-methylen-3-oxo-17alfa-pregn-4-en-21,17-carbolactoner, fremgangsmaade til deres fremstilling og farmaceutiske praeparater indeholdende dem
GB1433701A (en) 5-6-benzene ring substituted benzimidazole-2-carbamate derivative having anthelmintic activity apparatus
ES8304087A1 (es) "un metodo de preparar derivados de pirazolina".
ES466371A1 (es) Procedimiento para la preparacion de derivados de acilamino (alcohil)-benceno.
HUP9903880A2 (hu) Naftokinonszármazékok, eljárás az előállításukra, valamint hatóanyagként e vegyületeket tartalmazó fungicid, inszekticid és akaricid készítmények, eljárás az alkalmazásukra
ES8308539A1 (es) Procedimiento de preparar derivados de cloruro de aminosulfenilo, utiles para insecticidas
JPS5517323A (en) Substituted oxime ether, its preparation, and insecticide and miticide containing the same
JPS5443435A (en) Weight coefficient generating method for code check
ES481059A1 (es) Procedimiento para la preparacion de compuestos fenilen- o ciclohexilen-bis (2-propinilicos).
Endo et al. An Experiment of Block Adjustment using The Program Package “PAT-M”
AU3176197A (en) Pesticides
JPS5418606A (en) Recovery control system for multiple fault of information frame
JPS56167677A (en) Preparation of 2-benzyl-4-halomethylfuran
UA6776A (uk) Спосіб боротьби з буряковою нематодою
TH14339EX (th) กรรมวิธีใหม่สำหรับผลิตอนุพันธ์ 13-อีเธอร์ของมิลบีไมซิน, และอินเทอร์มิเดียทชนิดใหม่ของสารดังกล่าว
PT84979A (en) Process for preparing insecticidal compositions containing a mixture of cis-and trans-9-dodecenyl acetates for combatting grafe mothes (eupoecilia ambiguella)
DK679787A (da) Allenylaminer, fremgangsmaade til deres fremstilling og farmaceutiske praeparater deraf

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application